Richmond, VA, United States of America

Hope Patricia Bailey

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Haleon US Holdings LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hope Patricia Bailey. Retrieved from https://idiyas.com/inventor/hope-patricia-bailey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hope Patricia Bailey: Pharmaceutical Formulation Inventor

Introduction

Hope Patricia Bailey is an inventor associated with Richmond, Virginia, and Haleon US Holdings LLC. Her patent work addresses the formulation of pharmaceutical ingredients that are chemically incompatible when combined.

Latest Patents

Bailey is named on 1 patent, titled “Alkali Metal Salt Combinations of Incompatible Active Pharmaceutical Ingredients.” The patent describes an aqueous composition containing an alkali metal salt of a first pharmaceutical ingredient and a second ingredient that is chemically incompatible with it. The first ingredient may be ibuprofen or naproxen, while the second may be acetaminophen.

Career Highlights

Bailey’s patent reflects work on combining active pharmaceutical ingredients in an aqueous solution despite their chemical incompatibility. This formulation approach is relevant to the development of pharmaceutical products containing commonly used pain-relief ingredients.

Collaborations

Her listed coworkers include Gary Bruce Anderson and Shivangi Akash Patel. Their shared association with the patent record connects their work to pharmaceutical formulation innovation.

Conclusion

Hope Patricia Bailey’s patent focuses on aqueous formulations that bring chemically incompatible pharmaceutical ingredients together, highlighting her contribution to pharmaceutical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…